• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    DIH Appoints Haapsalu Neurological Rehabilitation Center as a DIH Center of Excellence

    8/30/24 8:00:00 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care
    Get the next $DHAI alert in real time by email

    NORWELL, Mass. and HAAPSALU, Estonia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced that Haapsalu Neurological Rehabilitation Center (HNRC), located in Haapsalu, Estonia, has been appointed as the latest DIH Center of Excellence. Recognized for its pioneering work in neurological rehabilitation, Haapsalu Neurological Rehabilitation Center is now the first such center in the Baltics Region.

    The DIH Center of Excellence program recognizes strategic partners that showcase best practices in rehabilitation robotics while demonstrating how DIH therapy solutions contribute to successful patient outcomes. These Centers also contribute to the development of advanced rehabilitation technologies.

    Founded in 1958, HNRC has a longstanding reputation for providing inpatient and outpatient rehabilitation services for children and adults with neurological disorders. Over the decades, the hospital has evolved into a modern rehabilitation facility, offering a full spectrum of care that spans from acute early rehabilitation to long-term social rehabilitation, tailored to meet the unique needs of each patient. With a deep commitment to improving patient outcomes, HNRC not only focuses on hands-on treatment but also actively contributes to research and development in the field of neurological rehabilitation.

    Haapsalu Neurological Rehabilitation Center utilizes DIH's advanced robotic rehabilitation technologies, including Hocoma's Lokomat®Pro, designed to provide intensive gait therapy for adult and pediatric patients with moderate to severe impairments in walking and functional mobility. The hospital also employs multiple Erigo® devices for early patient mobilization and safe verticalization, along with the Armeo®Spring for upper extremity rehabilitation. By combining these innovative technologies with the expertise of its clinical team, HNRC offers a comprehensive, individualized approach to rehabilitation, ensuring high-quality care tailored to each patient's needs.

    "We are pleased to welcome Haapsalu Neurological Rehabilitation Center as the first DIH Center of Excellence in the Baltics Region," said Slavko Škafar, Senior Vice President of Sales DIH - EMEA. "Their commitment to integrating our cutting-edge solutions into patient care not only enhances the quality of rehabilitation services but also sets a new standard for neurorehabilitation. We are excited to deepen our collaboration and continue driving innovation in the field."

    Kadri Englas, Chairman of the Board, Haapsalu Neurological Rehabilitation Center, added, "It is an honor to be recognized for what we do. We have implemented innovative technologies since 2012, and are convinced they add value to neurorehabilitation from the perspective of both patients and specialists. We will be happy to share our experience to colleagues and contribute our thoughts in developing the technologies further."

    About DIH Holding US, Inc.

    DIH stands for the vision to "Deliver Inspiration & Health" to improve the daily lives of millions of people with disabilities and functional impairments through providing devices and solutions enabling intensive rehabilitation. DIH is a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Built through the mergers of global-leading niche technology providers, DIH is a transformative rehabilitation solutions provider and consolidator of a largely fragmented and manual-labor-driven industry.

    About Haapsalu Neurological Rehabilitation Center (HNRC)

    HNRC is the only dedicated rehabilitation hospital in Estonia, belonging to the Estonian National Hospital Network. HNRC's mission is to help people become more active and pleased with life. HNRC provides tailored support to their patients using more than 65 years of experience, contemporary knowledge, and well-kept skills. HNRC is a learning organization – dedication to constant development has brought them to among noticeable neurorehabilitation centers and guides them further in their vision of becoming one of the best in their sector. HNRC believes that neurorehabilitation will never function without people – their wisdom, strength, and empathy – but innovative technical solutions are of definite help to empower their goals and to spare them from physical hardship.

    Caution Regarding Forward-Looking Statements



    This press release contains certain statements which are not historical facts, which are forward-looking statements within the meaning of the federal securities laws, for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These forward-looking statements include certain statements made with respect to the business combination, the services offered by DIH and the markets in which it operates, and DIH's projected future results. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions provided for illustrative purposes only, and projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These risks and uncertainties include, but are not limited to: general economic, political and business conditions; the ability of DIH to achieve its projected revenue, the failure of DIH realize the anticipated benefits of the recently-completed business combination and access to sources of additional debt or equity capital if needed. While DIH may elect to update these forward-looking statements at some point in the future, DIH specifically disclaims any obligation to do so.

    Investor Contact

    Greg Chodaczek

    [email protected]



    Primary Logo

    Get the next $DHAI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DHAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DHAI
    Leadership Updates

    Live Leadership Updates

    See more
    • DIH Appoints Shepherd Center as a DIH Center of Excellence

      NORWELL, Mass. and ATLANTA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Shepherd Center as DIH Center of Excellence. Through this partnership, DIH and Shepherd Center aim to further enhance rehabilitation outcomes and drive advancements in rehabilitation, creating new opportunities for patient recovery. The DIH Center of

      12/23/24 7:00:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Appoints Sheltering Arms Institute as a DIH Center of Excellence

      NORWELL, Mass. and RICHMOND, Va., Dec. 16, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the designation of Sheltering Arms Institute, a collaboration with VCU Health, as DIH Center of Excellence. By partnering with Sheltering Arms Institute, DIH continues to build a strong presence among top-tier healthcare providers dedicated to enhancing patient re

      12/16/24 4:05:00 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Appoints Dietmar Dold as Chief Operating Officer

      NORWELL, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today announced the appointment of Mr. Dietmar Dold as Chief Operating Officer, effective immediately.  Mr. Dold brings to DIH over 25 years of operating experience across multiple industries, and has demonstrated significant expertise in driving innovative transformation on a global scale. In his role as Chief Operating Officer, Mr. Dold will define and lead DIH's multi-group operating strategy, where he is expected to optimize manufacturing and sourcing initiatives, buil

      11/4/24 8:17:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

      SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

      11/14/24 6:07:49 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

      SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

      11/14/24 12:46:18 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D filed by DIH Holdings US Inc.

      SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)

      2/20/24 5:18:47 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DIH Announces Third Quarter 2025 Financial Results

      NORWELL, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the third fiscal quarter ended December 31, 2024. Recent Highlights Revenue of $15.1 million for the quarter ended December 31, 2024, representing a decline of 21% over the prior year periodDevice revenue of $11.7 million and service reven

      2/14/25 5:07:01 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Expands Strategic Partnership with Zahrawi Group

      NORWELL, Mass. and DUBAI, United Arab Emirates, Feb. 04, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the expansion of their strategic partnership with Zahrawi Group (MTC Company), DIH's representative and sales partner, to include Saudi Arabia.  Building on a successful collaboration that started in 2019, the partnership now spans four countries: th

      2/4/25 8:00:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Announces Closing of $4.6 Million Public Offering

      NORWELL, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the closing of its previously announced public offering of an aggregate of 5,937,100 units at a public offering price of $0.7832 per unit. Each unit consists of one share of Class A common stock and one Class A warrant to purchase one share of Class A common stock

      2/3/25 4:05:00 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Baucus Max was granted 52,817 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:26 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Director Chen Cathryn was granted 105,634 shares and acquired 4,885,173 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:23 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Director Eberts F Samuel Iii was granted 105,634 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:23 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    SEC Filings

    See more
    • SEC Form 424B3 filed by DIH Holdings US Inc.

      424B3 - DIH HOLDING US, INC. (0001883788) (Filer)

      5/5/25 4:35:42 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B3 filed by DIH Holdings US Inc.

      424B3 - DIH HOLDING US, INC. (0001883788) (Filer)

      5/5/25 4:30:39 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Holdings US Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - DIH HOLDING US, INC. (0001883788) (Filer)

      5/2/25 4:30:14 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care